ENDP : Summary for Endo International plc - Ordina - Yahoo Finance

U.S. Markets closed

Endo International plc (ENDP)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
13.08-0.22 (-1.65%)
At close: 4:00PM EST
People also watch
VRXMYLPRGOALXNUTHR
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close13.30
Open13.21
Bid13.03 x 500
Ask13.45 x 1000
Day's Range12.95 - 13.34
52 Week Range11.37 - 54.79
Volume5,470,329
Avg. Volume5,924,160
Market Cap2.92B
Beta-0.18
PE Ratio (TTM)-22.83
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • CNW Group6 days ago

    Endo to Announce Fourth-Quarter and Full-Year 2016 Financial Results

    Endo to Announce Fourth-Quarter and Full-Year 2016 Financial Results

  • PR Newswire6 days ago

    Endo to Announce Fourth-Quarter and Full-Year 2016 Financial Results

    DUBLIN, Feb. 13, 2017 /PRNewswire/ --   Endo International plc (NASDAQ / TSX: ENDP) will announce its fourth-quarter and full-year 2016 financial results and provide an update on its ongoing corporate ...

  • Barrons.com9 days ago

    Is More Downside Ahead For Teva Pharmaceutical?

    Less than a week has gone by since Teva Pharmaceutical Industries (TEVA) announced the sudden departure of CEO Erez Vigodman , the latest in a string of stock price-depleting news from the generic drug giant. Irina R. Koffler and Andrew Galler downgraded the drug maker from a neutral to an underperform and cut the stock's price target from $40 a share to $27 a share. 2) Teva's interim CEO may further reduce the 2017 outlook on Monday's earnings call and there could be additional mgmt.